[8] A couple of meta-analyses have shown that patients with preexisting COPD have greatly aggravated symptoms and a 4-5.9-fold greater risk of developing severe form of COVID-19 compared to patients without COPD. A single-center, case-series study [7] reported that COPD patients were more vulnerable to develop the more severe form of COVID-19 disease than those who do not have COPD. A patient with COPD presenting in Type 2 respiratory failure with their exacerbation should be considered for NIV if indicated as per the current COPD treatment guidelines (even though NIV is not recommended for COVID alone as a bridge to IPPV). Recommendations on use of inhaled corticosteroids in chronic obstructive pulmonary disease COPD patients on inhaled corticosteroids (ICS) should not discontinue ICS because of the fear of developing viral or bacterial pneumonias during the COVID pandemic. [Extracted from the article]